Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis

被引:23
|
作者
Gillham, M. I. [1 ]
Sundaram, S. [2 ]
Laughton, C. R. [1 ]
Haworth, C. S. [2 ]
Bilton, D. [3 ]
Foweraker, J. E. [1 ]
机构
[1] Papworth Hosp, Dept Microbiol, Cambridge CB23 3RE, England
[2] Papworth Hosp, Lung Def Unit, Cambridge CB23 3RE, England
[3] Royal Brompton Hosp, Dept Resp Med, London SW3 6NP, England
关键词
P; aeruginosa; morphotypes; disc diffusion; cystic fibrosis; CYSTIC-FIBROSIS; ANTIMICROBIAL RESISTANCE; STRAINS; SPUTA;
D O I
10.1093/jac/dkp007
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
To investigate variability in colony morphology and antibiotic susceptibility in populations of Pseudomonas aeruginosa from sputa of patients with bronchiectasis without cystic fibrosis (CF) compared with P. aeruginosa isolated from patients with CF, and from other infections as controls. P. aeruginosa was cultured from 31 patients with non-CF bronchiectasis, 24 with CF, 7 ventilated patients and 9 skin swabs. Four colonies of each morphotype of P. aeruginosa were tested for susceptibility to 12 antibiotics by disc diffusion. The variability in susceptibility between the isolates in each patient's population of P. aeruginosa was investigated. The classic morphotype of P. aeruginosa was cultured from control samples with an average variation in zone size of 2 mm (range 0-4 mm) for the four colonies tested. Non-CF bronchiectasis sputa contained 1-3 colonial morphotypes of P. aeruginosa; the average difference between the largest and smallest zone sizes found in all examples of the morphotypes present in each sample varied from 3 mm (1-9 mm) for colistin to 8 mm (0-24 mm) for piperacillin/tazobactam. CF sputa contained 2-6 morphotypes of P. aeruginosa with a wider variation of susceptibility. There was variation between bacteria of the same morphotype from non-CF bronchiectasis and CF sputa. Phenotypic variation in colonial form and antibiotic susceptibility is not unique to chronic infection in CF but is also found in non-CF bronchiectasis. This questions the use of current susceptibility testing methods for the complex populations of bacteria found in chronic lung infection.
引用
收藏
页码:728 / 732
页数:5
相关论文
共 50 条
  • [31] In Vitro Antibiotic Susceptibility of Pseudomonas aeruginosa Corneal Ulcer Isolates
    Gupta, Shikha
    Mittal, Sudeep
    Nayak, Niranjan
    Satpathy, Gita
    Khokhar, Sudarshan
    Agarwal, Tushar
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2015, 23 (03) : 252 - 255
  • [32] Decreased Antibiotic Susceptibility in Pseudomonas aeruginosa Surviving UV Irradition
    Li, Hai-bei
    Hou, Ai-ming
    Chen, Tian-jiao
    Yang, Dong
    Chen, Zheng-shan
    Shen, Zhi-qiang
    Qiu, Zhi-gang
    Yin, Jing
    Yang, Zhong-wei
    Shi, Dan-yang
    Wang, Hua-ran
    Li, Jun-wen
    Jin, Min
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [33] Arginine or nitrate enhances antibiotic susceptibility of Pseudomonas aeruginosa in biofilms
    Borriello, G
    Richards, L
    Ehrlich, GD
    Stewart, PS
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) : 382 - 384
  • [34] EVOLUTIONARY REVERSALS OF ANTIBIOTIC RESISTANCE IN EXPERIMENTAL POPULATIONS OF PSEUDOMONAS AERUGINOSA
    Gifford, Danna R.
    MacLean, R. Craig
    EVOLUTION, 2013, 67 (10) : 2973 - 2981
  • [35] Inhaled Colistin in Patients with Bronchiectasis and Chronic Pseudomonas aeruginosa Infection
    Haworth, Charles S.
    Foweraker, Juliet E.
    Wilkinson, Peter
    Kenyon, Robert F.
    Bilton, Diana
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189 (08) : 975 - 982
  • [36] Treatment with tobramycin solution for inhalation in bronchiectasis patients with Pseudomonas aeruginosa
    Couch, LA
    CHEST, 2001, 120 (03) : 114S - 117S
  • [37] Atorvastatin as novel treatment in bronchiectasis patients colonized with pseudomonas aeruginosa
    Bedi, Pallavi
    Chalmers, James
    Sarvanamuthu, Pira
    Rossi, Adriano
    Hill, Adam
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [38] Antibodies against Pseudomonas aeruginosa in patients with bronchiectasis:: helpful or harmful?
    Hoiby, N
    THORAX, 2001, 56 (09) : 667 - 668
  • [39] Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa
    Orriols, R
    Roig, J
    Ferrer, J
    Sampol, G
    Rosell, A
    Ferrer, A
    Vallano, A
    RESPIRATORY MEDICINE, 1999, 93 (07) : 476 - 480
  • [40] Aminoglycoside use for pseudomonas aeruginosa in bronchiectasis
    Fernandes, Michele
    Gatheral, Timothy
    Dhunnookchand, Ryan
    Bilton, Diana
    Wilson, Robert
    Loebinger, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44